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Protein splicing is a posttranslational autocatalytic process in which
an intervening sequence, termed an intein, is removed from a host
protein, the extein. Although we have a reasonable picture of the
basic chemical steps in protein splicing, our knowledge of how
these are catalyzed and regulated is less well developed. In the
current study, a combination of NMR spectroscopy and segmental
isotopic labeling has been used to study the structure of an active
protein splicing precursor, corresponding to an N-extein fusion of
the Mxe GyrA intein. The 1JNC coupling constant for the (1)
scissile peptide bond at the N-extein–intein junction was found to
be 12 Hz, which indicates that this amide is highly polarized,
perhaps because of nonplanarity. Additional mutagenesis and
NMR studies indicate that conserved box B histidine residue is
essential for catalysis of the first step of splicing and for maintain-
ing the (1) scissile bond in its unusual conformation. Overall,
these studies support the ‘‘ground-state destabilization’’ model as
part of the mechanism of catalysis.
Protein splicing is an autocatalytic process in which an internalintein domain excises itself from a host protein, the extein. The
first intein was discovered in 1990 as a spacer within the Saccha-
romyces cerevisiae vacuolar ATPase gene (1, 2). Since then, 100
putative members of this protein domain family have been identi-
fied from all three branches of life (3). In addition, a growing
number of proteins have been shown to contain autoprocessing
domains that are orthologous to inteins at the structural andor
mechanistic levels (e.g., refs. 4–7). There are three broad categories
of inteins: (i) Maxi-inteins, the largest class, contain a homing
endonuclease domain inserted into the core intein sequence (Fig.
1A). This endonuclease domain is not required for splicing activity
and can be deleted (8). (ii)Mini-inteins lack a homing endonuclease
domain and are consequently much smaller in size. (iii) Trans-
splicing inteins lack a peptide linkage between the N- and C-
terminal halves of the domain. Thus, the intein is split in two and
splicing only occurs on reconstitution of the fragments. All three
classes of inteins are characterized by several conserved sequence
motifs (blocks A, B, F, and G) containing the critical residues for
catalyzing the splicing reaction (Fig. 1A). Indeed, with one excep-
tion (noted below), there are no sequence requirements in the
extein in order for splicing to take place, and so intein activity is
promiscuous with respect to the extein.
The mechanism of protein splicing has been studied extensively
by using biochemical approaches (Fig. 1A) (9). The first step in the
standard protein splicing mechanism involves an N 3 S (or N3
O) acyl shift in which the N-extein unit is transferred to the
sidechain SH or OH group of a CysSer residue, located at the
immediate N terminus of the intein. Next, the entire N-extein unit
is transferred to a second conserved CysSerThr residue at the
intein–C-extein boundary (1 position within the C-extein) in a
transesterification step. The resulting branched intermediate is then
resolved through a cyclization reaction involving a conserved
asparagine residue at the C terminus of the intein. The intein is thus
excised as a C-terminal succinimide derivative. In the final step, an
amide bond is formed between the two exteins following an S3N
(or O3 N) acyl shift. This is known to be a spontaneous chemical
rearrangement (10) and presumably does not require the intein.
Although we have a reasonable overview of the various steps in
protein splicing, the mechanistic details of autocatalysis remain
poorly understood. There have been several high-resolution crystal
structures of inteins (11–16) and related proteins (5, 7, 17). These
structures have shed some light on the mechanism of the first step
in protein splicing, the N3 S (or N3 O) acyl shift. As illustrated
in Fig. 1B, the highly conserved block B His and Thr residues are
located close to the scissile (1) amide bond in all of the intein
structures determined to date. The imidazole side chain of the
conserved histidine (His-75 in Mycobacterium xenopi DNA gyrase
A, Mxe GyrA) seems to be positioned to participate in general
acidbase type catalysis, whereas the threonine appears to be part
of a oxyanion hole that would stabilize the presumed tetrahedral
oxythiazolidine intermediate (Fig. 1B).
Perhaps the most remarkable feature of these structural studies
relates to the conformation of the scissile (1) peptide bond itself.
In cases where N-extein residues were actually present in the
crystallized constructs, the (1) amide has been found in a variety
of conformations ranging from normal trans (15, 16) to distorted
trans (13) to a cis configuration (12). This has led to the hypothesis
that the scissile (1) peptide bond is activated toward nucleophilic
attack by distortion away from the most stable trans configuration,
the strain being imposed by specific tertiary interactions involving
conserved intein residues (Fig. 1B). Although intriguing, there are
twomajor caveats to this ‘‘ground-state destablization’’ model; first,
an unusual (1) amide conformation is not found in all N-extein–
intein crystal structures (15, 16), and second, all of the structures
solved to date involved inteins inactivated through mutation of
conserved residues. For example, in theMxeGyrA intein structure,
Cys-1 was mutated to a serine. Moreover, the construct contained
only a single N-extein residue and consequently the positively
charged-amino groupwas very close to the active site of the intein.
Conceivably, these mutationsalterations could have affected the
(1) amide conformation.
Clearly, it would be desirable to obtain a crystal structure of an
active N-extein–intein precursor. This has proven difficult because
of the short half-life of splicing precursors, on the order of a few
hours (18, 19). Indeed, an active S. cerevisiae vacuolar ATPase (Sce
VMA) intein has been shown to catalyze protein splicing within the
crystalline lattice (15). Thus, there is no information currently
available regarding the conformation of the scissile (1) amide
bond in an activeN-extein–intein precursor. In the present study, we
set out to address this issue by using a combination of solutionNMR
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spectroscopy and segmental isotopic labeling. Specifically, NMR
was used to study the structure of the (1) amide in an active
protein splicing precursor, prepared by semisynthesis, correspond-
ing to an N-extein fusion of the Mxe GyrA intein.
Materials and Methods
Peptide Synthesis. The peptide, H-AAMR[13C]F-SR, was synthe-
sized on a 3-mercaptopropionamide-4-methylbenzhydrylamine
(MBHA) resin (20) by using the in situ neutralization
2-(hydroxybenzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexa-
fluorophosphate (HBTU) activation protocol for Boc-SPPS (21).
After chain assembly, the peptide -thioester was cleaved off the
resin with anhydrous HF containing 4% volvol p-cresol (1 h, 4°C)
and purified by preparative reverse phase HPLC (RP-HPLC)
(Vydac C18, 15–20 M, 50 mm 250 mm) using a linear gradient
of 13.5–31.5% B (9:1 MeCNwater, 0.1% trifluroacetic acid) over
60 min at a flow rate of 30 mlmin to give 40 mg of purified peptide
[electrospray mass spectrometry (ESMS), obtained  684.1 mz
(MH), expected  682.9 mz (MH)].
Cloning and Protein Expression. The DNA encoding theMxe GyrA
intein (residues 1–198) was amplified by PCR using the pTXB1
vector (New England Biolabs) as a template. Note that pTXB1
encodes the GyrA intein with a single mutation, Asn-198 3 Ala,
which prevents cleavage of the intein–C-extein peptide bond.
Importantly, this mutation does not affect the N-terminal splicing
reaction (22), which is the focus of this study, and for clarity is
referred to as the wild-type sequence hereafter. For construction of
the plasmid pTrcHis-Xa-GyrAwt, which encodes a factorXa cleavage
sequence between a poly(His) tag and the intein, the appropriate
PCR product was cloned into the pTrcHisA vector (Invitrogen) by
using BamHI andHindIII restriction sites. This expression plasmid
was used as a template for site-directed mutagenesis with the
QuikChange site-directed mutagenesis kit (Stratagene). This re-
sulted in the generation of the following expression vectors:
pTrcHis-Xa-GyrAT72V; pTrcHis-Xa-GyrAN74A; pTrcHis-Xa-
GyrAH75A; pTrcHis-Xa-GyrAT72VN74A; pTrcHis-Xa-GyrAT72VH75A;
and pTrcHis-Xa-GyrAN74AH75A. The plasmid pTrcHis-SH3-GyrAWT,
which encodes the central Src homology 3 (SH3) domain of murine
c-Crk-II between a poly(His) tag and the intein, was a gift from
Vasant Muralidharan (Rockefeller University, New York). For
protein expression, Escherichia coli BL21 (DE3) cells, transformed
with the appropriate plasmid, were grown to mid-log phase at 37°C
in LB medium. For 15N-labeled proteins, the LB media was
replaced with M9 minimal medium, supplemented with 0.2%
(wtvol) [15N]NH4Cl. Protein expression was induced with 0.4 mM
isopropyl -D-thiogalactoside (IPTG) at 37°C for 5 h, after which
cells were harvested and lysed by passage through a French press.
Fusion proteins were purified by affinity chromatography using a
Ni2 high-trap column (Amersham Pharmacia) and dialyzed into
Fig. 1. The mechanism of protein splicing. (A) (Upper) Schematic illustrating the conserved regions within the intein domain family. The white bar represents
the intein primary structure with conserved blocks A, B, F, and G indicated by colored boxes. The homing endonuclease domain found in the majority of inteins
is also indicated. Conserved residues implicated in the splicing mechanism are shown below the bar. (Lower) The basic protein splicing mechanism. Note that
a small number of inteins contain an Ala as the first residue, rather than Cys or Ser. These inteins are thought to directly use the1 nucleophile within the C-extein
in the first step (40). (B) (Upper) Ribbon representation of the Mxe GyrA crystal structure with the active site residues indicated in ball and stick (12). (Lower)
Diagram of the N-terminal splice junction of the Mxe GyrA intein. The scissile (1) amide is highlighted in red, and purple lines indicate possible hydrogen bond
interactions to this amide with corresponding distances in Å.
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50 mM Tris, pH 81 mM EDTA buffer. All proteins were judged
to be 90% pure based on SDSPAGE, RP-HPLC, and ESMS
analyses.
N-Terminal Cleavage Assay. Cleavage reactions were initiated by
diluting (1:1) the freshly dialyzedHis–Xa–GyrA fusion protein into
DTT cleavage buffer (50 mM Tris, pH 8100 mMDTT). Aliquots
of the cleavage reactions were removed, quenched by adding
guanidinium chloride (GdmCl) (to a final concentration of 6 M),
and then analyzed by analytical RP-HPLC. Reaction progress was
monitored by integration of the starting material peak in the
chromatograms. The data from the time courses were then fit to a
first-order rate function (Table 1). All kinetic measurements were
carried out at least in duplicate.
Generation of [U-15N]GyrA and [U-15N]GyrA(H75A). [U-15N]GyrA
was prepared by incubating the purified [U-15N]His-SH3–GyrA
fusion protein overnight in DTT cleavage buffer.
[U-15N]GyrA(H75A) was generated by incubating purified
[U-15N]His–Xa–GyrA(H75A) with factor Xa in proteolysis buffer
(50 mM Tris, pH 80.1 M NaCl1 mM CaCl2) for 10 h at room
temperature. Both proteins were then purified to 95% homoge-
neity by preparative RP-HPLC and characterized by ESMS:
[U-15N]GyrA, observed 21,524 3 Da, calculated 21,529 Da;
[U-15N]GyrA(H75A), observed  21,464  4 Da, expected 
21,460 Da.
Preparation of AAMR[13C]F-[U-15N]GyrA (1) and AAMR[13C]F-
[U-15N]GyrA(H75A) (2). Segmentally labeled proteins were obtained
by chemically ligating H-AAMR[13C]F-SR with either
[U-15N]GyrA or [U-15N]GyrA(H75A). Ligation reactions were
initiated by dissolving purified, lyophilized peptide (10 eq) and
protein (1 eq) in ligation buffer (6 MGdmCl0.1 M NaPi at pH 8)
containing 3% MESNA and 2% ethanethiol. The final concentra-
tion of protein was1 mM, and the final concentration of peptide
was 10 mM. In both cases, the ligation reaction was found to be
complete after 5 h incubation at room temperature. The ligation
products (1 and 2) were then purified by preparativeRP-HPLC and
characterized by ESMS: 1, observed 22,101 4 Da, expected
22,107 Da; 2, observed  22,045  3 Da, expected  22,038 Da.
Purified proteins 1 and 2 (1mgml) were folded by stepwise dialysis
from denaturing buffer (6MGdmCl0.1 MNaCl20 mMKPi, pH
6.61 mM DTT) into NMR sample buffer (0.1 M NaCl20 mM
KPi, pH 6.6) at 4°C.
NMR Spectroscopy. NMR samples were prepared by concentrating
(100 M) labeled proteins (1 and 2) in NMR sample buffer
containing 10% D2O and 0.01% NaN3. 1H{15N} HSQC (hetero-
nuclear single quantum correlation) and 2D planes of HNCO
spectra were collected at 4°C on aBrukerAvance-800 spectrometer
with a cryo-probe. For the HSQC experiments, we collected 512
complex points in the 1H and 15N dimensions. In the 2D H{N}CO
experiments, we collected 512 complex points in the 1H dimension
and 40 complex points in the 13C dimension. Data sets were
multiplied by a cosine-bell window function and zero-filled to 1,000
points before Fourier transformation using XWINNMR (Bruker
Instruments). The corresponding sweep widths were 12.5 ppm, 12
ppm, and 30 ppm in the 1H, 13C, and 15N dimensions, respectively.
Experimental amide 1JNC coupling constants were obtained by
fitting the time evolution of the normalized peak intensities ex-
tracted from the series of HNCO-type experiments using the
expression
Ik  e(4t1R2k) sin2(2JktI), [1]
where Ik are the normalized peak intensities for peak k, R2 is the
transverse relaxation time for peak k, and t1 is the indirect
dimension delay (23).
Results
TheMxeGyrA intein was chosen for our studies for several reasons.
First, a high-resolution crystal structure of an inactivemutant of the
protein is available (12), which was used to guide the mutagenesis
studies described below. Second, this intein can be efficiently
refolded from the denatured state (24), a property that was key to
the semisynthesis of an active N-extein–intein precursor. Last, the
relatively small size of this miniintein makes it more suitable for
NMR studies than maxiinteins such as the Sce VMA intein.
Site-Directed Mutagenesis of the Mxe GyrA Intein. The crystal struc-
ture of the Mxe GyrA intein (12) revealed three residues in close
proximity to the scissile (1) peptide bond; Thr-72, Asn-74, and
His-75, all from conserved block B (Fig. 1A). These residues are
thought to be critical for activating the amide bond toward nucleo-
philic attack by the Cys thiolate. Mutation of the block B Thr and
His residues has been found to abolish, or significantly impair,
splicing in the Sce VMA intein (25); however, the effect of such
mutations on Mxe GyrA intein activity has not been reported.
Consequently, a series of N-extein–GyrA intein fusion proteins
were generated in which the three block B residues were mutated
individually or in pairwise combinations. These constructs con-
tained an N-terminal His-tag, for purification, fused via a short
peptide to the intein.
The ability of the inteinmutants to catalyze the initial N3 S acyl
shift was determined by measuring the rate of thiol-induced cleav-
age of the N-extein peptide from the intein. The results of these
experiments are summarized in Table 1. For the wild-type intein,
the apparent first order rate constant for cleavage was 1  103
s1, which is in excellent agreement with similar measurements
made on other inteins (18, 19). Mutation of Thr-72 and Asn-74
reduced the cleavage rate by 5- and 10-fold, respectively, indicating
that these residues are important, but not essential for splicing
activity. Indeed, the double mutant Thr-723 ValAsn-743 Ala
was still able support robust N-terminal cleavage. In contrast, the
His-75 3 Ala mutation essentially abolished N-terminal splicing
activity, and only trace amounts of cleavage products could be
detected after 24 h of incubation in cleavage buffer. This result is
consistent with His-75 having an essential catalytic role in the
splicing activity of the GyrA intein; however, it is equally possible
that theAlamutation resulted in a gross reorganization of the intein
structure. This possibility was investigated byNMRspectroscopy, as
described below.
Semisynthesis of Segmental Isotopic-Labeled Proteins. Two segmen-
tal isotopic labeled constructs were prepared for NMR studies.
These corresponded to a short N-extein peptide followed by either
the wild-type GyrA intein sequence or the His75Ala mutant
thereof. The N-extein sequence, AAMRF, was based on the native
residues in the gyrA gene with the exception that, for synthetic
reasons, the phenylalanine replaced a tyrosine. In both cases, the
intein was uniformly labeled with 15N, whereas the N-extein com-
ponent contained a single 13C isotope at the C position of the Phe.
Table 1. First-order rate constants for thiolysis of N-extein–GyrA
intein fusions
Protein Kobs, sec1 t12
WT 9.8 (0.9)  104 11.8 min
T72V 2.5 (0.4)  104 46.2 min
N74A 9.3 (0.8)  105 2 h
H75A Trace –
T72VN74A 6.2 (0.3)  105 3.1 h
T72VH75A Trace –
N74AH75A Trace –








This segmental labeling pattern served two purposes; first, it
allowed the folded state of the intein to be evaluated from the
1H{15N}HSQC fingerprint, and second, it provided a unique
spectral handle on the scissile (1) peptide bond because only this
amide is dual-labeled (Fig. 2A).
The two constructs AAMR[13C]F-[U-15N]-GyrA (1) and
AAMR[13C]F-[U-15N]-GyrA(H75A) (2) were prepared by ex-
pressed protein ligation (EPL) (26). This involved chemical ligation
of a synthetic peptide -thioester, H-AAMR[13C]F-SR, to the
appropriate uniformly 15N labeled recombinant GyrA intein pos-
sessing an N-terminal Cys residue. The peptide building block was
prepared by Boc-Na-SPPS, whereas the protein building block was
generated by thiolysis (wild-type GyrA) or proteolysis (mutant
GyrA) of the appropriate GyrA-fusion protein (Fig. 2A). Ligation
reactions were initiated bymixing an excess of the synthetic peptide
with the intein in a buffer containing thiols and 6 M GdmCl. The
presence of denaturant was essential to prevent in situ thiolysis of
the product during the ligation reaction; this would have occurred
under native conditions, at least for the wild-type intein. Both
ligation reactions were complete after5 h as judged byHPLC and
mass spectrometry (Fig. 2B). The ligation products, 1 or 2, were
each purified by preparative-scale RP-HPLC and then refolded by
stepwise dialysis into nonreducing phosphate buffer at pH 6.5.
Treatment of refolded construct 1 with N-terminal cleavage buffer
resulted in quantitative cleavage of the free N-extein peptide from
the intein, indicating that the protein had the native intein fold after
the refolding procedure.
Because the principal goal of this study was to perform NMR
experiments on active splicing precursor 1, it was important to
determine the stability of this molecule in NMR sample buffer (20
mM potassium phosphate, pH 6.60.1 M NaCl). This buffer does
not contain any thiol reducing agents (unlike the DTT-containing
buffers used in the N-cleavage reactions), and so N-terminal
cleavage would have to involve hydrolysis of the thioester linkage
rather than thiolysis, which should be quite a slow process at pH 6.6
and 4°C. Indeed, refolded protein 1 was found to be quite stable in
this buffer, as determined by HPLC and MS analyses, with 10%
N-terminal cleavage observed after 18-h incubation. Moreover, no
evidence of cysteine oxidation was observed at this time point. As
expected, the amount of cleavage products did accumulate with
time, which places some restrictions of the duration of the NMR
experiments to be performed. This problem is, to some extent,
alleviated by the availability of cryogenic probes and ultra-high field
NMR spectrometers.
Solution NMR Studies. NMR spectroscopy was used to study the
solution structure of purified semisynthetic constructs 1 and 2. Of
initial interest was the effect of theHis75Alamutation on the global
fold of the intein. Because constructs 1 and 2 each contain a
uniformly 15N-labeled intein domain, comparison of the 1H{15N}
HSQC spectra should reveal any gross structural reorganization
caused by the mutation. As shown in Fig. 3, there is in fact a high
degree of spectral overlap between the two 1H{15N} HSQC fin-
gerprint regions. Indeed, both spectra have well dispersed signals
indicative of a defined tertiary fold with the expected predomi-
Fig. 2. Segmental isotopic labeling of N-extein–intein constructs. (A) Ex-
pressed protein ligation strategy used to prepare constructs 1 and 2. This
semisynthetic route results in only the scissile (1) amide being dual labeled
with 13C and 15N. (B) Electrospray mass spectra of purified 1 and 2. Expected
masses for 1 and 2 are 22,107 Da and 22,038 Da, respectively.
Fig. 3. Solution NMR spectra of segmental isotopic labeled constructs 1 and 2. (A) 1H{15N} HSQC spectra of AAMR[13C]F-[U-15N]-GyrA (1). (B) 1H{15N} HSQC
spectra of AAMR[13C]F-[U-15N]-GyrA(H75A) (2). (C) Comparison of the reconstructed 1H{15N} HSQC spectra of constructs 1 (circles) and 2 (crosses) using chemical
shifts extracted from individual spectra (A and B). Chemical shifts of Cys-1 HN bond are highlighted by squares.
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nantly -sheet structure (12). Although the vast majority of the
resolvable crosspeaks are superimposable, a small number of signals
can be observed that are unique to one or other of the spectra
(highlighted in Fig. 3C). The spectral similarity factor (27) between
the two is 16 Hz, which is indicative of some, but not dramatic,
changes. Because the N-extein sequence is identical in proteins 1
and 2, these differences presumably reflect localized structural
changes andor magnetic shielding effects resulting from removal
of the imidazole ring. Nonetheless, it is clear that the His75Ala
mutation, which renders the intein inactive, does not result in a
global reorganization of tertiary structure. This argues that His-75
has an essential catalytic role in the splicing activity of the GyrA
intein.
The dual-isotopic labeling pattern in constructs 1 and 2 allowed
the unequivocal assignment of the scissile (1) amide resonances
from the HN plane of the HNCO spectra (Fig. 3 and supporting
information, which is published on the PNAS web site). Compar-
ison of these spectra reveals that the (1) amide resonances of 2 are
all shifted downfield relative to 1. Themost dramatic effect is on the
amide proton, which shifts from 6.61 ppm in construct 1 to 10.01
ppm in construct 2. The magnitude of this shift is remarkable and
reflects the fact that the (1) amide proton is unusually upfield
shifted in the spectrum of 1 and downfield shifted in the spectrum
of 2.
Assignment of the scissile (1) amide resonances allowed the
one-bond dipolar coupling to be measured for constructs 1 and 2.
Experimental amide 1JNC coupling constants were obtained by
fitting the time evolution of the normalized peak intensities ex-
tracted from the series ofHNCO-type experiments according to the
method of Bax et al. (23). Accordingly, the 1JNC coupling constants
for the scissile (1) amide in 1 and 2 were found to be 12.3  0.3
Hz and 16.2  0.2 Hz, respectively (Fig. 4).
Discussion
The first step in protein splicing involves an N3 S (or N3 O)
acyl shift and results in the entire N-extein acyl unit being
transferred to the side chain of the first residue of the intein. This
rearrangement is chemically unfavorable because it breaks an
amide bond and forms a high-energy (thio)ester linkage. With
the exception of inteins and related autoprocessing proteins
(e.g., refs. 4–7), this reaction is not known to occur spontane-
ously in proteins. Moreover, the reaction does not take place
when an intein is chemically or thermally denatured. Thus, the
chemical rearrangement must be catalyzed by structure–activity
relationships within the intein. Several crystal structures of
inteins are available. These reveal a homologous -fold termed
the HINT domain (also found in certain autoprocessing do-
mains; ref. 17) and, not surprisingly, an active site sprinkled with
conserved residues. However, these structures have provided
less information about autocatalysis, in large part because they
involve either free inteins or extein fusions of mutant inteins
unable to catalyze splicing reactions. Thus, how the N 3 S(O)
acyl shift is self-catalyzed by the intein is still an unsolved
problem.
This study describes our initial efforts to understand the catalytic
basis of protein splicing. Our view is that insights into autocatalysis
will require the structural analysis of active protein splicing pre-
cursors involving, as far as possible, wild-type inteins and exteins.
Such an approach is greatly complicated by the short half-life of
extein–intein fusions (18, 19). Indeed, we have measured the
half-life of an N-extein–GyrA fusion to be12 min in the presence
thiol cleaving agents (Table 1). To get around this problem, we used
a combination of modern NMR instrumentation (i.e., ultra-high
field spectrometers coupled with cryogenic probes) and site-
specifically labeled protein splicing precursors. We devised a semi-
synthetic route to N-extein fusions of theMxe GyrA intein (Fig. 2)
that allows site-specific incorporation of spectroscopic probes. In
the present study, this was used to prepare multimilligram amounts
of segmental isotopically labeled constructs, 1 and 2, in which only
the scissile (1) amide bonds were dual-labeled with 13C and 15N
isotopes. Importantly, this labeling pattern allowed the straightfor-
ward assignment of the (1) amide resonances using 2D HNCO
NMR experiments.
The chemical shift of the (1) amide proton in 1 (i.e., NH of
Cys-1) is significantly upfield shifted (  6.61 ppm) compared to
the random coil value for cysteine (28). In contrast, neither the 13C
nor 15N chemical shifts in the (1) amide are unusually upfield or
downfield shifted (Fig. 3 and supporting information). Backbone
amide 1H chemical shifts are known to be sensitive to ring current
fields and hydrogen-bonding networks (29). Inspection of theGyrA
crystal structure (12) suggests that shielding effects from the nearest
aromatic side chain, the imidazole ring of His-75, should be quite
modest. Indeed, the chemical shift prediction program, SHIFTS (30),
which uses the published coordinate file as input, predicts a small
positive (0.01 ppm) ring current effect on the (1) amide proton.
Nonetheless, we do observe that removal of this imidazole ring, i.e.,
in construct 2, results in a downfield shift of all of the (1) amide
resonances (Fig. 3) and so it is possible that the position of this
side-chain is subtly different in construct 1 than in the GyrA intein
construct used in the crystallographic study. It is also worth noting
that constructs 1 and 2 both contain a phenylalanine at the first
position in theN-extein. Conceivably, the ring current field from the
phenyl ring could influence the (1) amide chemical shifts in 1 and
2. In terms of hydrogen bonding, short bond lengths are generally
associated with downfield shifts of amide 1H and longer bond
lengths with upfield shifts (31). Based on the crystal structure, the
side chains of residues Thr-72, Asn-74, andHis-75 are all candidates
for a putative long-range H-bonds to the (1) amide (Fig. 1B).
Fig. 4. Determination of the 1JNC coupling constant for the scissile (1)
amide in constructs 1 and 2. The time evolution of the normalized peak
intensities extracted from a series of H(N)CO experiments was nonlinearly fit
to Eq. 1 to give the single-bond coupling constants. (A) Fit obtained for
construct 1, 1JNC  12.3  0.3 Hz and R2  17.3  0.3 s1. (B) Fit obtained for
construct 2, 1JNC  16.2  0.2 Hz and R2  17.5  0.4 s1.








Moreover, it is also possible that the scissile amide forms H-bonds
to a residue(s) in the N-extein peptide. Indeed, in the crystal
structure of glycosylasparaginase, which also undergoes an auto-
processing reaction involving an N 3 O shift, the scissile amide
appears to be hydrogen-bonded to the side chain of an upstream
Asp residue (5).
In addition to an unusual 1H chemical shift, the scissile peptide
bond in construct 1 has an abnormally low one bond dipolar
coupling, 1JNC  12.3  0.3 Hz. As with amide chemical shifts,
amide 1JNC values have been shown to correlate with hydrogen
bonding, in this caseH-bonding to the amide carbonyl increases the
coupling constant, whereas H-bonding to the amide hydrogen
decreases the coupling constant (32–34). This effect can be under-
stood in terms of lengthening or shortening the CON bond
resulting frompolarization of the electrons across the amide. 1JNC
values have been reported for several proteins (34, 35) and are
typically in the range 13–17Hz. Themeasured 1JNC coupling for the
(1) amide of 1 is among the lowest reported in a protein to date.
This could indicate an extremely strong H-bond involving the NH
group; however, this interpretation is inconsistent with the upfield
chemical shift observed for this amide proton. Paradoxically, the
1JNC coupling for the (1) amide in inactive construct 2 is a more
normal 16.2 0.2Hz, yet the amide 1H exhibits a striking downfield
shift compared to 1, 	  3.4 ppm.
The backbone around the scissile (1) peptide bond has been
found to be in a distorted conformation in the crystal structures of
two proteins, the Sce VMA intein (13) and glycosylasparaginase,
which, as noted above, also undergoes autoproteolysis (5). Indeed,
in the glycosylasparaginase structure, the planarity of scissile pep-
tide bond ( value) deviated from ideality ( 180°) by20°. Such
a distortionwould result in a significant loss in delocalization energy
because of the breakdown  symmetry and it has been proposed
that this activates the scissile peptide bond toward nucleophilic
attack (5). Indeed, twisted amide bonds are known to be signifi-
cantly more susceptible to alkaline hydrolysis than planar amides.
Rate enhancements as high as 107 (10 kcalmol1) have been
reported (36), and recent theoretical studies suggest that the loss of
 resonance is the major reason for this rate acceleration (37). The
effect of C(O)ON bond rotation on NMR chemical shifts has been
studied by using a series of twisted amides (38). A loss of amide
planarity was associated with upfield and downfield shifts in the 15N
and 13C amide signals, respectively. Based on these observations,
one would expect that the amide 1H chemical shift would also shift
upfield as a result of C(O)ON bond rotation. The effect of amide
nonplanarity on the 1JNC coupling has not been studied in a
systematic fashion. In principle, the 1JNC coupling should decrease
with increasing rotation of the C(O)ONbond because this will also
increase the C(O)ON bond length (38). Indeed, simply density
function theory quantum mechanical calculations on N-methyl-
acetamide indicate that, as one might expect, 1JNC varies signifi-
cantly as the cosine of (supporting information). Surprisingly, Bax
and coworkers (35) found no obvious correlation between the 1JNC
coupling and the nonplanarity of the peptide bonds in Staphylo-
coccal nuclease. However, they did note that such a correlation
could have beenmasked by uncertainties in the crystallographically
determined  values. It should also be added that the reported 
values for the backbone amides in this protein do not deviate
significantly from ideality.
It is tempting to speculate that the extremely low 1JNC coupling
observed for the scissile amide in active construct 1 is evidence of
backbone distortion, particularly because inactive construct 2 has a
significantly higher 1JNC coupling more typical of what is generally
seen in proteins. The difference in 1JNC between 1 and 2 is
especially intriguing in light of two recent crystallographic studies
on the Sce VMA intein (13, 15). One of these structures revealed
backbone distortions around the scissile (1) peptide bond, spe-
cifically  for the 1 residue measured 100° (13), whereas these
distortions were not observed in the other structure (15). Interest-
ingly, the block B His was present in the construct used in the first
structure but was mutated in the construct used in the second, just
as in our constructs, 1 and 2. Although additional studies, perhaps
involving the use of multiple vicinal couplings (39), will be required
to more precisely characterize the solution conformation of the
scissile amide in the GyrA intein, our NMR data clearly indicate
that the peptide bond in theGyrA intein is unusually polarized, and
that the side chain of His-75 is absolutely required for this effect.
These data provide additional support for the idea that the first step
in protein splicing is facilitated, in part, by destabilizing the scissile
amide bond. Future studies will need to explore this idea further
and exploit our ability to prepare semisynthetic versions of the
GyrA intein.
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